Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New Frontiers in Pharma R&D Investment

Nov 01 2009

Related Content

Revised Alexza Deal Suggests Updated Strategy For Symphony Capital

Jul 06 2009

Corporate VC Adds a Business Development Flavor

Nov 01 2007

Lilly's Chorus Experiment

May 01 2007

Lilly and Merck Lead the Way With Asian FIPNet Strategies

May 01 2008

Alzheimer's Development Financing: Risky Therapies Call for Innovative Deals

Sep 01 2008

GSK Tries to Mimic Real-World Biotech

Feb 01 2009

Symphony's Project Financing Model Adapts

Jan 01 2009

Corporate Venture Takes Center Stage

May 01 2009

Related Companies

Novartis AG

GSK plc

GSK plc

Enlight Biosciences LLC

Eli Lilly and Company

Pfizer Inc.

Merck & Co., Inc.

Amgen, Inc.

Biogen, Inc.

Jubilant Life Sciences Ltd.

Piramal Enterprises Limited

Ranbaxy Laboratories Limited

Daiichi Sankyo Co., Ltd.

Suven Life Sciences Ltd.

HUTCHMED (China) Limited

HUTCHMED (China) Limited

Bristol Myers Squibb Company

AstraZeneca PLC

IQVIA Holdings Inc.

PPD, Inc.

Alexza Pharmaceuticals, Inc.

Oncotelic Therapeutics, Inc.

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window